What is NDC 72241-011?

72241-011 is the product NDC for Rivastigmine Tartrate, Rivastigmine tartrate 1.5 mg/1 capsule, listed with the FDA by Modavar Pharmaceuticals LLC. It has 2 package NDCs, shown above in 10- and 11-digit form.

Modavar Pharmaceuticals LLC, NDC labeler code 72241. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Rivastigmine Tartrate?

36 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Rivastigmine Tartrate NDC 72241-011

NDC codes

FDA NDC Directory

Product NDC (as listed)72241-011Labeler and product segments. Claims need a package NDC.

Product NDC at billing width72241-0011Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
72241-011-03	7224100110372241001103	60 CAPSULE in 1 BOTTLE (72241-011-03)Marketed from Oct 5, 2021
72241-011-10	7224100111072241001110	500 CAPSULE in 1 BOTTLE (72241-011-10)Marketed from Oct 5, 2021

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Rivastigmine Tartrate
Generic name (nonproprietary): rivastigmine tartrate
Active ingredients: Rivastigmine tartrate — 1.5 mg/1
Dosage form: Capsule
Route: Oral
Labeler: Modavar Pharmaceuticals LLCNDC labeler code 72241
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 203844
Marketing start: Oct 5, 2021
Listing expires: Dec 31, 2026
Other FDA classes: Cholinesterase Inhibitors (Mechanism)
Identifiers: Product ID 72241-011_27f32649-68c4-4f16-abaf-35cba6ac6b75SPL ID 27f32649-68c4-4f16-abaf-35cba6ac6b75SPL set ID 209f3b02-0acf-46e9-b355-91c918a20eb3RxCUI 312835, 312836, 314214, 314215UNII 9IY2357JPEUPC 0372241014031, 0372241012037, 0372241011030
Pharmacologic class: Cholinesterase Inhibitor

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N472241001103 followed by a unit qualifier and the quantity

Package 72241-0011-03. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Dec 28, 2022.

Indications (excerpt from the label)

1 INDICATIONSAND USAGE Rivastigmine tartrate is an acetylcholinesterase inhibitor indicated for treatment of: • Mild-to-moderate dementia of the Alzheimer's type (AD) ( 1.1 ) • Mild-to-moderate dementia associated with Parkinson's disease (PD) ( 1.2 ) 1.1 Alzheimer's Disease Rivastigmine tartrate capsules, USP are indicated for the treatment of mild-to-moderate dementia of the Alzheimer's type (AD). 1.2 Parkinson's Disease Dementia Rivastigmine tartrate capsules, USP are indicated for the treatment of mild-to-moderate dementia associated with Parkinson's disease (PD).

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 72241-011

What is NDC 72241-011?: 72241-011 is the product NDC for Rivastigmine Tartrate, Rivastigmine tartrate 1.5 mg/1 capsule, listed with the FDA by Modavar Pharmaceuticals LLC. It has 2 package NDCs, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Rivastigmine Tartrate.
What is the active ingredient?: Rivastigmine tartrate.
Who is the labeler?: Modavar Pharmaceuticals LLC, NDC labeler code 72241. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Rivastigmine Tartrate?: 36 other product NDCs are listed under this name. See all Rivastigmine Tartrate NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Rivastigmine Tartrate NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Rivastigmine Tartrate	Rivastigmine tartrate 1.5 mg/1	CapsuleOral	American Health Packaging	60687-777	60687-0777-01
Rivastigmine Tartrate	Rivastigmine tartrate 1.5 mg/1	CapsuleOral	Alembic Pharmaceuticals Inc.	62332-063	62332-0063-1062332-0063-3062332-0063-60+2 more
Rivastigmine Tartrate	Rivastigmine tartrate 3 mg/1	CapsuleOral	Alembic Pharmaceuticals Inc.	62332-064	62332-0064-1062332-0064-3062332-0064-60+2 more
Rivastigmine Tartrate	Rivastigmine tartrate 4.5 mg/1	CapsuleOral	Alembic Pharmaceuticals Inc.	62332-065	62332-0065-1062332-0065-3062332-0065-60+2 more
Rivastigmine Tartrate	Rivastigmine tartrate 6 mg/1	CapsuleOral	Alembic Pharmaceuticals Inc.	62332-066	62332-0066-1062332-0066-3062332-0066-60+2 more
Rivastigmine Tartrate	Rivastigmine tartrate 3 mg/1	CapsuleOral	Modavar Pharmaceuticals LLC	72241-012	72241-0012-0372241-0012-10
Rivastigmine Tartrate	Rivastigmine tartrate 4.5 mg/1	CapsuleOral	Modavar Pharmaceuticals LLC	72241-013	72241-0013-0372241-0013-10
Rivastigmine Tartrate	Rivastigmine tartrate 6 mg/1	CapsuleOral	Modavar Pharmaceuticals LLC	72241-014	72241-0014-0372241-0014-10
Rivastigmine Tartrate	Rivastigmine tartrate 1.5 mg/1	CapsuleOral	Chartwell RX, LLC	62135-900	62135-0900-60
Rivastigmine Tartrate	Rivastigmine tartrate 3 mg/1	CapsuleOral	Chartwell RX, LLC	62135-901	62135-0901-60

All 37 Rivastigmine Tartrate NDCs

Other NDCs under ANDA 203844

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 203844
Product	Strength	Form · route	Labeler	Product NDC
Rivastigmine Tartrate	Rivastigmine tartrate 1.5 mg/1	CapsuleOral	Cadila Pharmaceuticals Limited	71209-012
Rivastigmine Tartrate	Rivastigmine tartrate 3 mg/1	CapsuleOral	Cadila Pharmaceuticals Limited	71209-013
Rivastigmine Tartrate	Rivastigmine tartrate 4.5 mg/1	CapsuleOral	Cadila Pharmaceuticals Limited	71209-014
Rivastigmine Tartrate	Rivastigmine tartrate 6 mg/1	CapsuleOral	Cadila Pharmaceuticals Limited	71209-015
Rivastigmine Tartrate	Rivastigmine tartrate 3 mg/1	CapsuleOral	Modavar Pharmaceuticals LLC	72241-012
Rivastigmine Tartrate	Rivastigmine tartrate 4.5 mg/1	CapsuleOral	Modavar Pharmaceuticals LLC	72241-013
Rivastigmine Tartrate	Rivastigmine tartrate 6 mg/1	CapsuleOral	Modavar Pharmaceuticals LLC	72241-014